Amandine Quivy

504 total citations
9 papers, 351 citations indexed

About

Amandine Quivy is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Amandine Quivy has authored 9 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Amandine Quivy's work include Renal cell carcinoma treatment (3 papers), Renal and related cancers (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Amandine Quivy is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Renal and related cancers (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Amandine Quivy collaborates with scholars based in France and United States. Amandine Quivy's co-authors include Alain Ravaud, Marine Gross‐Goupil, Charlotte Domblides, Amaury Daste, Pierre Soubeyran, Camille Chakiba, Erwan de Monès, Nicolas Larmonier, Mathieu Larroquette and Guilhem Roubaud and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Cancer Management and Research.

In The Last Decade

Amandine Quivy

9 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amandine Quivy France	6	214	121	83	73	38	9	351
Lorenz Jost Switzerland	8	142 0.7×	102 0.8×	79 1.0×	99 1.4×	49 1.3×	11	342
Ana T. Nunes United States	11	275 1.3×	70 0.6×	120 1.4×	81 1.1×	39 1.0×	19	455
Yiying Guo China	10	257 1.2×	81 0.7×	153 1.8×	68 0.9×	27 0.7×	26	421
Pauline du Rusquec France	10	225 1.1×	160 1.3×	93 1.1×	55 0.8×	37 1.0×	25	400
Amy Barone United States	9	217 1.0×	87 0.7×	102 1.2×	92 1.3×	20 0.5×	14	396
Marye J. Boers‐Sonderen Netherlands	14	346 1.6×	114 0.9×	194 2.3×	92 1.3×	29 0.8×	43	523
Danae Hamouda United States	11	230 1.1×	67 0.6×	156 1.9×	81 1.1×	29 0.8×	33	460
Jun Koshio Japan	6	247 1.2×	125 1.0×	167 2.0×	78 1.1×	35 0.9×	11	464
Melinda Laine Hsu United States	11	214 1.0×	119 1.0×	160 1.9×	111 1.5×	23 0.6×	28	422
Krzysztof Leśniewski-Kmak Poland	11	256 1.2×	148 1.2×	121 1.5×	65 0.9×	31 0.8×	31	477

Countries citing papers authored by Amandine Quivy

Since Specialization

Citations

This map shows the geographic impact of Amandine Quivy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amandine Quivy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amandine Quivy more than expected).

Fields of papers citing papers by Amandine Quivy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amandine Quivy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amandine Quivy. The network helps show where Amandine Quivy may publish in the future.

Co-authorship network of co-authors of Amandine Quivy

This figure shows the co-authorship network connecting the top 25 collaborators of Amandine Quivy. A scholar is included among the top collaborators of Amandine Quivy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amandine Quivy. Amandine Quivy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Larroquette, Mathieu, Charlotte Domblides, Amandine Quivy, et al.. (2021). Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A review. European Journal of Cancer. 158. 47–62. 53 indexed citations

Domblides, Charlotte, et al.. (2020). <p>Management of Immune Checkpoint Inhibitor Toxicities</p>. Cancer Management and Research. Volume 12. 9139–9158. 26 indexed citations

Frison, Éric, Marine Gross‐Goupil, Charlotte Domblides, et al.. (2019). Outcomes and toxicities in sarcopenic patients with metastatic solid tumors treated with check point inhibitors.. Journal of Clinical Oncology. 37(15_suppl). e14166–e14166. 2 indexed citations

Daste, Amaury, Charlotte Domblides, Marine Gross‐Goupil, et al.. (2017). Immune checkpoint inhibitors and elderly people: A review. European Journal of Cancer. 82. 155–166. 139 indexed citations

Daste, Amaury, et al.. (2016). Efficacy of Rechallenge of Metastatic Renal Cell Carcinoma Patient With Sunitinib After Prior Resistance to Axitinib: Case Report and Review of the Literature. Clinical Genitourinary Cancer. 14(5). e525–e527. 1 indexed citations

Daste, Amaury, Camille Chakiba, Charlotte Domblides, et al.. (2016). Targeted therapy and elderly people: A review. European Journal of Cancer. 69. 199–215. 28 indexed citations

Roubaud, Guilhem, Véronique Brouste, Aude Fléchon, et al.. (2015). Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients. Journal of Negative Results in BioMedicine. 14(1). 18–18. 2 indexed citations

Domblides, Charlotte, Marine Gross‐Goupil, Amandine Quivy, & Alain Ravaud. (2013). Emerging antiangiogenics for renal cancer. Expert Opinion on Emerging Drugs. 18(4). 495–511. 13 indexed citations

Gross‐Goupil, Marine, et al.. (2013). Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma. Clinical Medicine Insights Oncology. 7. 269–77. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact